Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1968 Mar 16;98(11):524–531.

Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings.

K N Drummond, D A Hillman, J H Marchessault, W Feldman
PMCID: PMC1923912  PMID: 5643296

Full text

PDF
524

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. A., Gordon A., Maxwell M. H. Azathioprine treatment of immunological renal disease. JAMA. 1967 Feb 13;199(7):459–463. [PubMed] [Google Scholar]
  2. CHURG J., GRISHMAN E., GOLSTEIN M. H., YUNIS S. L., PORUSH J. G. IDIOPATHIC NEPHROTIC SYNDROME IN ADULTS. A STUDY AND CLASSIFICATION BASED ON RENAL BIOPSIES. N Engl J Med. 1965 Jan 28;272:165–174. doi: 10.1056/NEJM196501282720401. [DOI] [PubMed] [Google Scholar]
  3. COLDBECK J. H. EXPERIENCE WITH ALKYLATING AGENTS IN THE TREATMENT OF CHILDREN WITH THE NEPHROTIC SYNDROME. Med J Aust. 1963 Dec 14;2:987–989. [PubMed] [Google Scholar]
  4. CONEN P. E., LANSKY G. S. Chromosome damage during nitrogen mustard therapy. A case report. Br Med J. 1961 Oct 21;2(5259):1055–1057. doi: 10.1136/bmj.2.5259.1055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Drummond K. N., Michael A. F., Good R. A., Vernier R. L. The nephrotic syndrome of childhood: immunologic, clinical, and pathologic correlations. J Clin Invest. 1966 Apr;45(4):620–630. doi: 10.1172/JCI105376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Etteldorf J. N., Roy S., 3rd, Summitt R. L., Sweeney M. J., Wall H. P., Berton W. M. Cyclophosphamide in the treatment of idiopathic lipoid nephrosis. J Pediatr. 1967 May;70(5):758–766. doi: 10.1016/s0022-3476(67)80327-5. [DOI] [PubMed] [Google Scholar]
  7. GOODMAN H. C., WOLFF S. M., CARPENTER R. R., ANDERSEN B. R., BRANDRISS M. W. CURRENT STUDIES ON THE EFFECT ANTIMETABOLITES IN NEPHROSIS, OTHER NON-NEOPLASTIC DISEASES, AND EXPERIMENTAL ANIMALS. COMBINED CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH. Ann Intern Med. 1963 Sep;59:388–407. doi: 10.7326/0003-4819-59-3-388. [DOI] [PubMed] [Google Scholar]
  8. Grupe W. E., Heymann W. Cytotoxic drugs in steroid-resistant renal disease. Alkylating and antimetabolic agents in the treatment of nephrotic syndrome, lupus nephritis, chronic glomerulonephritis, and purpura nephritis in children. Am J Dis Child. 1966 Nov;112(5):448–458. doi: 10.1001/archpedi.1966.02090140120011. [DOI] [PubMed] [Google Scholar]
  9. LAGRUE G., BARIETY J., KERAUTEMY DE, SAMARCQ P., FRITEL D., DE BOISDEFFRE B., MILLIEZ P. R'ESULTATS DE LA CHIMIOTH'ERAPIE PROLONG'EE AU COURS DE CERTAINS SYNDROMES N'EPHROTIQUES. J Urol Nephrol (Paris) 1964 Mar;70:156–165. [PubMed] [Google Scholar]
  10. Michael A. F., Vernier R. L., Drummond K. N., Levitt J. I., Herdman R. C., Fish A. J., Good R. A. Immunosuppressive therapy of chronic renal disease. N Engl J Med. 1967 Apr 13;276(15):817–828. doi: 10.1056/NEJM196704132761501. [DOI] [PubMed] [Google Scholar]
  11. Northway J. D., West C. D. Successful therapy of trimethadione nephrosis with prednisone and cyclophosphamide. Report of a case. J Pediatr. 1967 Aug;71(2):259–263. doi: 10.1016/s0022-3476(67)80085-4. [DOI] [PubMed] [Google Scholar]
  12. Shearn M. A. Mercaptopurine in the treatment of steroid-resistant nephrotic syndrome. N Engl J Med. 1965 Oct 28;273(18):943–947. doi: 10.1056/NEJM196510282731801. [DOI] [PubMed] [Google Scholar]
  13. Swanson M. A., Schwartz R. S. Immunosuppressive therapy. The relation between clinical response and immunologic competence. N Engl J Med. 1967 Jul 27;277(4):163–170. doi: 10.1056/NEJM196707272770401. [DOI] [PubMed] [Google Scholar]
  14. WEST C. D. Use of combined hormone and mechlorethamine (nitrogen mustard) therapy in lipoid nephrosis. AMA J Dis Child. 1958 May;95(5):498–515. doi: 10.1001/archpedi.1958.02060050502007. [DOI] [PubMed] [Google Scholar]
  15. White R. H., Cameron J. S., Trounce J. R. Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome. Br Med J. 1966 Oct 8;2(5518):853–860. doi: 10.1136/bmj.2.5518.853. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES